BridgeMD
New treatment option for Acute Lymphoblastic Leukemia
Official title Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
ClinicalTrials.gov ID: NCT03932903
What this study is testing
- What it's testing
- This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 and older
You may be able to join if
- Ages 14-29
- Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
- In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
- Prescribed 6-mercaptopurine (6MP)
- English language proficiency
You likely can't join if
- Cognitive impairments that would limit ability to complete measures, determined by the medical team
- Absence of inclusion criteria above. Caregiver Inclusion Criteria:
- Nominated by the AYA as a primary caregiver involved in cancer care (can be a parent, relative, partner, friend)
- English language proficiency Caregiver Exclusion Criteria: \- Absence of inclusion criteria above.
See the full eligibility criteria
- Ages 14-29
- Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
- In the maintenance phase, completed at least one cycle and has at least one month of maintenance therapy remaining.
- Prescribed 6-mercaptopurine (6MP)
- English language proficiency
- For AYA \<18, must have informed consent from their caregiver. AYA
- Cognitive impairments that would limit ability to complete measures, determined by the medical team
- Absence of inclusion criteria above. Caregiver Inclusion Criteria:
- Nominated by the AYA as a primary caregiver involved in cancer care (can be a parent, relative, partner, friend)
- English language proficiency Caregiver Exclusion Criteria: \- Absence of inclusion criteria above.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.